Nika Pharmaceuticals Inc. (NIKA) Research

Nika Pharmaceuticals Inc., a pharmaceutical enterprise headquartered in Henderson, Nevada, focuses on the creation of medications to address a broad spectrum of health conditions. Its research and development efforts target serious diseases including HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, and diabetes. The company's product line features antiviral treatments and nutritional supplements, notably providing a specialized thymus nuclear glycoprotein for the management of HIV. Originally established in 2000, the organization was previously known as Centennial Growth Equities Inc. before adopting its current name, Nika Pharmaceuticals, Inc., in May 2022.

Market snapshot

Symbol
NIKA
Price
$0.51
Day change
0.00%
Market cap
$534.6M
P/E ratio
-6959.20x
52-week range
0.2-0.9574
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Alterola Biotech, Inc. (ABTI)
  • Benchmark Holdings plc (BHCCF)
  • Craftport Cannabis Corp. (BHHKF)
  • Cellectis S.A. (CMVLF)
  • Cogstate Limited (COGZF)
  • Cipher Pharmaceuticals Inc. (CPHRF)
  • Spectral Medical Inc. (EDTXF)
  • Frontage Holdings Corporation (FGHQF)

Open Nika Pharmaceuticals Inc. (NIKA) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.